Melanoma Physician

DANA-FARBER CANCER INSTITUTE

Dedicated to Discovery...Committed to Care Melanoma Physician The department of Medical Oncology at the Dana-Farber Cancer Institute and the Department of Medicine, Brigham and Women's Hospital, announce a search for a physician at the Instructor, Assistant Professor or Associate Professor level to join the Melanoma Program. The successful candidate will participate in an active clinical practice that is fully integrated within a large and growing clinical and translational research program. Interest and expertise in the conduct of clinical trials is desired. This is a full-time clinical position but there may be an opportunity to become a clinical investigator in the future. The successful candidate will also engage in teaching medical students, house staff and oncology fellows in the clinic and inpatient settings. The academic appointment will be at the Instructor, Assistant Professor or Associate Professor level at Harvard Medical School and determined by the applicant's credentials. Salary and benefits will be competitive with other institutions. Applicants should have an MD or MD/PhD degree and should be board certified or board eligible in Internal Medicine and Medical Oncology. Application deadline July 30, 2026. Interested candidates should submit a letter of interest by email along with their CV and the names and email addresses of three references to: Patrick Ott, M.D., Ph.D. Clinical Director, Melanoma Disease Center Department of Medical Oncology Professor of Medicine, Harvard Medical School Dana-Farber Cancer Institute 450 Brookline Avenue, Dana 2-130 Boston, MA 02215 E-mail: View email address on click.appcast.io We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, protected veteran status, pregnancy and pregnancy-related conditions or any other characteristic protected by law. #J-18808-Ljbffr American Society of Clinical Oncology (ASCO)